Literature DB >> 17719225

Cognitive side-effects of adjuvant treatments.

Harold J Burstein1.   

Abstract

Symptoms associated with cognitive dysfunction-difficulties with memory, concentration, and language-are frequent among breast cancer survivors after chemotherapy. The true incidence, functional significance, and causes of these symptoms remain unclear. Models of cognitive dysfunction suggest multiple possible contributors including changes in hormonal milieu, direct effects of chemotherapy, medications given as supportive care, psychiatric changes including depression and anxiety, and mediators of inflammation. Novel neuro-cognitive testing and imaging methods are being evaluated in breast cancer survivors to better understand cognitive side-effects of therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17719225     DOI: 10.1016/j.breast.2007.07.027

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  5 in total

1.  Regional brain activation during verbal declarative memory in metastatic breast cancer.

Authors:  Shelli R Kesler; F Chris Bennett; Misty L Mahaffey; David Spiegel
Journal:  Clin Cancer Res       Date:  2009-10-20       Impact factor: 12.531

2.  Preserved learning and memory following 5-fluorouracil and cyclophosphamide treatment in rats.

Authors:  Jeffrey M Long; Garrick D Lee; Bennett Kelley-Bell; Edward L Spangler; Evelyn J Perez; Dan L Longo; Rafael de Cabo; Sige Zou; Peter R Rapp
Journal:  Pharmacol Biochem Behav       Date:  2011-08-22       Impact factor: 3.533

3.  Reducing Heart Dose with Protons and Cardiac Substructure Sparing for Mediastinal Lymphoma Treatment.

Authors:  Kekoa Taparra; Scott C Lester; W Scott Harmsen; Molly Petersen; Ryan K Funk; Miran J Blanchard; Phillip Young; Joerg Herrmann; Ashley Hunzeker; Heather Schultz; Cynthia McCollough; Alexandria Tasson; Shuai Leng; James A Martenson; Thomas J Whitaker; Eric Williamson; Nadia N Laack
Journal:  Int J Part Ther       Date:  2020-09-04

4.  An awareness survey of surgeons involved in breast cancer treatment regarding their patients returning to work.

Authors:  Kazuhisa Akahane; Nobuyuki Tsunoda; Toru Murata; Masahiro Fujii; Yoshitaka Fuwa; Koji Wada; Koji Oda; Masato Nagino
Journal:  Nagoya J Med Sci       Date:  2014-08       Impact factor: 1.131

5.  Chemobrain experienced by breast cancer survivors: a meta-ethnography study investigating research and care implications.

Authors:  Maryam Hafsah Selamat; Siew Yim Loh; Lynette Mackenzie; Janette Vardy
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.